These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24239002)

  • 1. Chromogranin A is a T cell antigen in human type 1 diabetes.
    Gottlieb PA; Delong T; Baker RL; Fitzgerald-Miller L; Wagner R; Cook G; Rewers MR; Michels A; Haskins K
    J Autoimmun; 2014 May; 50():38-41. PubMed ID: 24239002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.
    Jin N; Wang Y; Crawford F; White J; Marrack P; Dai S; Kappler JW
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13318-23. PubMed ID: 26453556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.
    Delong T; Baker RL; He J; Barbour G; Bradley B; Haskins K
    Diabetes; 2012 Dec; 61(12):3239-46. PubMed ID: 22912420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A is an autoantigen in type 1 diabetes.
    Stadinski BD; Delong T; Reisdorph N; Reisdorph R; Powell RL; Armstrong M; Piganelli JD; Barbour G; Bradley B; Crawford F; Marrack P; Mahata SK; Kappler JW; Haskins K
    Nat Immunol; 2010 Mar; 11(3):225-31. PubMed ID: 20139986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
    Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K
    J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
    Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
    J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
    Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
    J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
    Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
    Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
    Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL
    Front Immunol; 2021; 12():668680. PubMed ID: 34113344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
    So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
    Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
    Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    Lombardi A; Concepcion E; Hou H; Arib H; Mezei M; Osman R; Tomer Y
    J Autoimmun; 2020 Dec; 115():102543. PubMed ID: 32951964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.
    Liu B; Hood JD; Kolawole EM; Woodruff DM; Vignali DA; Bettini M; Evavold BD
    Diabetes; 2020 Mar; 69(3):381-391. PubMed ID: 31806623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.
    Yang J; Chow IT; Sosinowski T; Torres-Chinn N; Greenbaum CJ; James EA; Kappler JW; Davidson HW; Kwok WW
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14840-5. PubMed ID: 25267644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
    Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
    Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.